Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 08, 2018 at 02:53 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 82.707 million compared to TWD 89.016 million a year ago. Operating income was TWD 342,000 compared to TWD 9.819 million a year ago. Net income was TWD 1.406 million compared to TWD 9.000 million a year ago. Basic earnings per share was TWD 0.05 compared to TWD 0.36 a year ago. Diluted earnings per share was TWD 0.05 compared to TWD 0.35 a year ago.
For the nine months, sales was TWD 250.926 million compared to TWD 275.161 million a year ago. Operating income was TWD 2.195 million compared to TWD 32.002 million a year ago. Net income was TWD 4.637 million compared to TWD 25.563 million a year ago. Basic earnings per share was TWD 0.17 compared to TWD 1.02 a year ago. Diluted earnings per share was TWD 0.17 compared to TWD 0.99 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.